-
Going Off-Label
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
-
Forward Look
Tackling Drug ResistanceResearchers are studing new ways to keep treatments working longer.
by Stephen Ornes
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
-
Survivor Profile
The Gift of MusicA self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
-
Forward Look
Breast Density MattersBreast cancer risk factor may be overlooked.
by Kendall K. Morgan
-
Revised Prostate Cancer Screening Guidelines Proposed
The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.
-
Forward Look
Advances in Treating Non–Small Cell Lung CancerExpanded approvals in 2016 increase options.
by Jennifer L.W. Fink
-
Yesterday & Today
TV’s Family ManMichael Landon, best known for his roles on Little House on the Prairie and Bonanza, created and starred in programs that portrayed family values with authenticity and humor.
by Marci A. Landsmann
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore